arrow
N

Noemi Castelletti

Institute of Infectious Diseases and Tropical Medicine
H指数:16
被引数:855

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A dried blood spot protocol for high-throughput semi-quantitative analysis of Epstein-Barr Virus VCA IgG and EBNA IgG serologies based on the Roche Elecsys system

基于罗氏Elecsys系统的高通量半定量分析EB病毒VCA IgG和EBNA IgG血清学的干血斑检测方案

2026-07-230
OAAI
Understanding the Omicron Variant Impact in Healthcare Workers: Insights from the Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf) on Risk Factors for Breakthrough and Reinfections
2024-09-301
OAAI
Studying temporal titre evolution of commercial SARS-CoV-2 assays reveals significant shortcomings of using BAU standardization for comparison
2023-09-014
OAAI
The Prospective COVID-19 Post-Immunization Serological Cohort in Munich (KoCo-Impf): Risk Factors and Determinants of Immune Response in Healthcare Workers
2023-07-183
OAAI
The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant
2023-07-133
OAAI
Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion
2023-05-2417
OAAI
Impact of Omicron Variant Infection on Assessment of Spike-Specific Immune Responses Using the EUROIMMUN Quan-T-Cell SARS-CoV-2 Assay and Roche Elecsys Anti-SARS-CoV-2-S

Omicron变体感染对使用EUROIMMUN Quan-T细胞SARS-CoV-2测定法和Roche Elecsys Anti-SARS-CoV-2-S评估刺突特异性免疫反应的影响

2023-03-082
OAAI
Enhanced Spike-specific, but attenuated Nucleocapsid-specific T cell responses upon SARS-CoV-2 breakthrough versus non-breakthrough infections

SARS-CoV-2突破与非突破感染相比,增强了刺突特异性但减弱了核衣壳特异性T细胞反应

2022-12-1311
OAAI
Determinants of Anti-S Immune Response at 9 Months after COVID-19 Vaccination in a Multicentric European Cohort of Healthcare Workers-ORCHESTRA Project
2022-11-287
OAAI
Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers - ORCHESTRA project
2022-09-2924
OAAI
Head-to-head evaluation of seven different seroassays including direct viral neutralisation in a representative cohort for SARS-CoV-2
2021-11-0124
OAAI
From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany)
2021-09-0821
OAAI
Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay
2021-05-2027
OAAI